Answers are grounded in this paper and cite their sources.
Our study highlights that CBD has an antiseizure effect comparable to other antiseizure medications with a positive safety profile independent of the epilepsy subtype. Comedication with clobazam was not associated with a better outcome. Higher doses to achieve seizure frequency reduction were safe, particularly in children. These findings call for further trials for an extended approval of CBD for other epilepsy subtypes and for children <2 years of age.
No takes yet. Share an insight, caveat, or question.
Kühne et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: